Caribou Biosciences (CRBU)’s CB-011 May Reach $734 Million in Peak 2040 Sales, According to Clear Street

A dose vessel of the medicine is successful the aesculapian tech's hand

On February 2, 2026, Clear Street began covering Caribou Biosciences, Inc. (NASDAQ:CRBU) with a ‘Buy’ standing and a $13 terms target. The firm’s bullish stance was attributed to the company’s off-the-shelf allogeneic CAR-T program, which was described arsenic the superior worth generator. The concern slope projected 2040 highest income of $992 cardinal with a 30% accidental of occurrence for the pb candidate, vispa-cel. Caribou is preparing to statesman a registrational Phase 3 proceedings successful second-line oregon aboriginal ample B-cell lymphoma. Additionally, with a 20% accidental of success, Clear Street forecasts that CB-011 whitethorn scope $734 cardinal successful highest 2040 sales, highlighting some objective hazard and upside potential.

On January 6, 2026, BofA cited a wider reset successful U.S. biopharma valuations, cutting its terms people connected Caribou Biosciences, Inc. (NASDAQ:CRBU) from $8 to $6 portion keeping a ‘Buy’ rating. Although durability remains the main constituent of contention for investors, the concern steadfast argued that amended entree to capital, M&A activity, and encouraging information catalysts bespeak a biotech turnaround.

Caribou Biosciences, Inc. (NASDAQ:CRBU) focuses connected advancing an interior oncology pipeline and supporting broader therapeutic and biotech probe uses by leveraging CRISPR genome-editing exertion to make off-the-shelf CAR-T and CAR-NK compartment treatments.

While we admit the imaginable of CRBU arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the champion short-term AI stock.

READ NEXT: What Are the Best Stocks to Buy Right Now? and 10 Stocks Under $1 That Will Explode.

Disclosure: None.